Guys, I know many of you will not want to hear about MSB, but in case you hadn't, they got $140 million of funding from a collective of spinal surgeons out of the US. Now how does this relate to PAR? They are an ambulatory (walk-in, walk-out) network of orthopedics in the US. That they are looking at alternatives to traditional arthroscopic surgeries in Australia bio-tech bodes well for PAR. I am sure it is not off their' and others' radars.
It would be a nice fit for PAR too. The event ultimately bodes well for more than one company in the Aussie bio-tech sphere.
A huge buying opportunity, page-34
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 429247 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 13806 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |